相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron
Zhen Cui et al.
CELL (2022)
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
Delphine Planas et al.
NATURE (2022)
Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants
Kang Wang et al.
NATURE (2022)
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
Yunlong Cao et al.
NATURE (2022)
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2
Lihong Liu et al.
NATURE (2022)
SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein-ACE2 complex
Dhiraj Mannar et al.
SCIENCE (2022)
Mapping cross-variant neutralizing sites on the SARS-CoV-2 spike protein
Shiqi Xu et al.
EMERGING MICROBES & INFECTIONS (2022)
Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody
Cheng Li et al.
CELL (2022)
Advances in antibody phage display technology
Line Ledsgaard et al.
DRUG DISCOVERY TODAY (2022)
Simultaneous measurement of the antibody responses against SARS-CoV-2 and its multiple variants by a phage display mediated immuno-multiplex quantitative PCR-based assay
Hanyi Chen et al.
FRONTIERS IN MICROBIOLOGY (2022)
Antibody evasion properties of SARS-CoV-2 Omicron sublineages
Sho Iketani et al.
NATURE (2022)
The impact of receptor-binding domain natural mutations on antibody recognition of SARS-CoV-2
Cheng Li et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Neutralizing monoclonal antibodies for treatment of COVID-19
Peter C. Taylor et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS
Yushun Wan et al.
JOURNAL OF VIROLOGY (2020)
A new coronavirus associated with human respiratory disease in China
Fan Wu et al.
NATURE (2020)
Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany
Camilla Rothe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia
Qun Li et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection
Junwen Luan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
Qihui Wang et al.
CELL (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
Xiaolong Tian et al.
EMERGING MICROBES & INFECTIONS (2020)
A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV
Meng Yuan et al.
SCIENCE (2020)
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
Xiuyuan Ou et al.
NATURE COMMUNICATIONS (2020)
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2
Rui Shi et al.
NATURE (2020)
Human neutralizing antibodies elicited by SARS-CoV-2 infection
Bin Ju et al.
NATURE (2020)
Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19
Yuan Huang et al.
ACTA PHARMACOLOGICA SINICA (2020)
Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy
Shuo Du et al.
CELL (2020)
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
Thomas F. Rogers et al.
SCIENCE (2020)
Phage Display: Simple Evolution in a Petri Dish (Nobel Lecture)
George P. Smith
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV
Guangyu Zhao et al.
JOURNAL OF VIROLOGY (2018)
Nanobodies®† as inhaled biotherapeutics for lung diseases
Gino Van Heeke et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Single-Domain Antibodies As Therapeutics against Human viral Diseases
Yanling Wu et al.
FRONTIERS IN IMMUNOLOGY (2017)
Nanobodies: Natural Single-Domain Antibodies
Serge Muyldermans
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 82 (2013)
LigPlot+: Multiple Ligand-Protein Interaction Diagrams for Drug Discovery
Roman A. Laskowski et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
Enhancement of toxin- and virus-neutralizing capacity of single-domain antibody fragments by N-glycosylation
M. M. Harmsen et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2009)
Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies
Zhongyu Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Human monoclonal antibody combination against SARS coronavirus: Synergy and coverage of escape mutants
Jan ter Meulen et al.
PLOS MEDICINE (2006)
Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association
JH Sui et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
分享论文
